FindMyKOL

Matthias Hofer, MD

Enriched profile

Assistant Professor · Northwestern University Feinberg School of Medicine

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized profile
Region🇺🇸 San Antonio, TX · South Central · United StatesSpecialtyUrologyFocusUrological Disorders and Treatments+4
Active KOLFindMyKOL type: EliteLatest publicationSee ScholarshipOnline presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Matthias Hofer is Assistant Professor at Northwestern University Feinberg School of Medicine. OpenAlex indexes 151 publications with 4,538 citations (h-index 37); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 9 Nov 2026

Overview

Updated 19 Nov 2026

Matthias Hofer, MD, is Assistant Professor at Northwestern University Feinberg School of Medicine. The public record shows 151 publications with 4,538 citations (h-index 37), centered on Urological Disorders and Treatments, Prostate Cancer Treatment and Research, Urinary Bladder and Prostate Research. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 22 companies.

  • Top research focus: Urological Disorders and Treatments
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 22 companies

Generated from the cited public record · current as of 19 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Calculi1 trialHyperplasia1 trialKidney Calculi1 trialProstatic Hyperplasia1 trialUreteral Calculi1 trialAtopic Dermatitis / EczemaBladder / Urothelial CancerBreast CancerColorectal CancerLung Cancer (NSCLC/SCLC)Pancreatic CancerProstate CancerKidney Cancer / RCCSubstance Use Disorders

Research focus

OpenAlex concept fingerprint
Urological Disorders and TreatmentsProstate Cancer Treatment and ResearchUrinary Bladder and Prostate ResearchProstate Cancer Diagnosis and TreatmentUreteral procedures and complications

Drugs & molecules

across trials, industry payments and publications
Aveedgeneric · TestosteroneClinical trials—Industry payments7Publications1Xiaflexgeneric · Collagenase Clostridium histolyticumClinical trials—Industry payments10Publications—Botoxgeneric · Botulinum toxin type AClinical trials—Industry payments7Publications—Orgovyxgeneric · RelugolixClinical trials—Industry payments4Publications—EDEXClinical trials—Industry payments2Publications—Eligardgeneric · LeuprolideClinical trials—Industry payments2Publications—Erleadageneric · ApalutamideClinical trials—Industry payments2Publications—Gemtesageneric · VibegronClinical trials—Industry payments2Publications—Pluvictogeneric · Vipivotide tetraxetanClinical trials—Industry payments2Publications—FluciclovineClinical trials—Industry payments1Publications—Imfinzigeneric · DurvalumabClinical trials—Industry payments1Publications—Myrbetriqgeneric · MirabegronClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Boston Scientific CorporationClinical trials—Industry payments116Coloplast CorpClinical trials—Industry payments16Axonics, Inc.Clinical trials—Industry payments7Endo Pharmaceuticals Inc.Clinical trials—Industry payments6Abbvie Inc.Clinical trials—Industry payments4Endo USA, Inc.Clinical trials—Industry payments4Allergan, Inc.Clinical trials—Industry payments3Astellas Pharma US IncClinical trials—Industry payments3Medtronic, Inc.Clinical trials—Industry payments3Myovant Sciences Inc.Clinical trials—Industry payments3Antares Pharma, Inc.Clinical trials—Industry payments2Janssen Biotech, Inc.Clinical trials—Industry payments2Novartis Pharmaceuticals CorporationClinical trials—Industry payments2Sumitomo Pharma America, Inc.Clinical trials—Industry payments2TOLMAR Pharmaceuticals, Inc.Clinical trials—Industry payments2Acerus Pharmaceuticals CorporationClinical trials—Industry payments1AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Avvio MedicalClinical trials1Industry payments—Blue Earth Diagnostics LimitedClinical trials—Industry payments1Laborie Medical Technologies Corp.Clinical trials—Industry payments1Northwestern UniversityClinical trials1Industry payments—Urovant Sciences IncClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
151publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

4,538citations

Citations across these publications.

37h-index

H-index from these publications. i10-index 67.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
22companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 9 Nov 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 9 Nov 2026

22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

  • Boston Scientific Corporation
    Program year202545 payments
    $14,478
  • Sumitomo Pharma America, Inc.
    Program year20252 payments
    $43
  • AstraZeneca Pharmaceuticals LP
    Program year20251 payment
    $35
All 39 payment records: search, sort and filter.Explore →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 9 Nov 2026

39 congress contributions (2004–2023) across AUA per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Network

Updated 9 Nov 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Allen F. Morey34Mark A. Rubin31Chris M. Gonzalez19Rainer Kuefer18Billy Hamilton Cordon16Matthew I. Bury14Jeremy M Scott13Joceline S. Liu12Arun K. Sharma11Francisco E. Martins9Arul M. Chinnaiyan9Stacy Loeb9Emily M. Yura9William J. Catàlona9Sven Perner9Sarah C. Flury9Brian T. Helfand9Yvonne Y. Chan8Earl Y. Cheng8Nicholas Kavoussi7Richard E. Hautmann7Juergen E. Gschwend7Boyd R. Viers6Tarek A. Bismar6Travis J. Pagliara6A. Descazeaud6Phillip R. Cooper6Stephanie Kielb6Daniel T. Oberlin5Jay Simhan5Oluwarotimi Sewedo Nettey5Claus G. Roehrborn5SHILAJIT D. KUNDU5Lee Cheng Zhao5Francesca Demichelis5Sooryanarayana Varambally5Krishnan Venkatesan5Qiaoyan Hu5Barry B. McGuire5Christopher Staniorski4

Online presence

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • X / Twitter

    x.com/Hoferurology

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • LinkedIn

    Urology San Antonio LinkedIn company page congratulates Matthias Hofer on FGPS

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 9 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.